• Aarti Sarwal, Chiara Robba, Carla Venegas, Wendy Ziai, Marek Czosnyka, and Deepak Sharma.
• Atrium Wake Forest School of Medicine, Winston-Salem, NC, USA. asarwal@wakehealth.edu.
• Neurocrit Care. 2023 Oct 1; 39 (2): 269283269-283.

AbstractCerebral autoregulation (CA) is a physiological mechanism that maintains constant cerebral blood flow regardless of changes in cerebral perfusion pressure and prevents brain damage caused by hypoperfusion or hyperperfusion. In recent decades, researchers have investigated the range of systemic blood pressures and clinical management strategies over which cerebral vasculature modifies intracranial hemodynamics to maintain cerebral perfusion. However, proposed clinical interventions to optimize autoregulation status have not demonstrated clear clinical benefit. As future trials are designed, it is crucial to comprehend the underlying cause of our inability to produce robust clinical evidence supporting the concept of CA-targeted management. This article examines the technological advances in monitoring techniques and the accuracy of continuous assessment of autoregulation techniques used in intraoperative and intensive care settings today. It also examines how increasing knowledge of CA from recent clinical trials contributes to a greater understanding of secondary brain injury in many disease processes, despite the fact that the lack of robust evidence influencing outcomes has prevented the translation of CA-guided algorithms into clinical practice.© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

18 keywords...

hide…